Adalimumab is safe and effective in re-inducing clinical remission after post-surgical relapse of Crohn's disease: A case report

  • Caprioli F
  • Viganò C
  • Botti F
 et al. 
  • 6

    Readers

    Mendeley users who have this article in their library.
  • 0

    Citations

    Citations of this article.

Abstract

We present the case of a 36-year-old patient with ileo-colonic stricturing Crohn's disease that recurred after surgery, did not respond to maximal medical therapy and was only partially responsive to treatment with adalimumab administered subcutaneously. The patient underwent surgery following an episode of intestinal obstruction, revealing chronic, adhesive peritonitis, with the intestinal loops fixed strongly together, and a fibrotic stricture of the pre-anastomotic ileum. The numerous adhesions were carefully separated and the stenotic tract of ileum was resected. Following the resection the patient had an early clinical relapse, which was documented by abdominal ultrasound. The patient was, therefore, treated again with adalimumab: the new cycle of treatment achieved clinical and ultrasonographic remission of the disease. Despite the previous treatment, no side-effects occurred. © 2010 Editrice Gastroenterologica Italiana S.r.l.

Author-supplied keywords

  • Anti-tumour necrosis factor alpha antibodies
  • Crohn's disease
  • Post-surgical relapse

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Authors

  • Flavio Caprioli

  • Chiara Viganò

  • Fiorenzo Botti

  • Ettore Contessini-Avesani

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free